Pondicherry Journal of Nursing

Register      Login

VOLUME 14 , ISSUE 1 ( January-March, 2021 ) > List of Articles

Original Article

A Study to Assess the Prevalence and Contributing Factors of Abnormal Uterine Bleeding among Women Admitted in MGMCRI from January to December 2019

R Iniyaval, B Jayanthi, Lavanya Sankar, K Renuka

Citation Information : Iniyaval R, Jayanthi B, Sankar L, Renuka K. A Study to Assess the Prevalence and Contributing Factors of Abnormal Uterine Bleeding among Women Admitted in MGMCRI from January to December 2019. 2021; 14 (1):8-10.

DOI: 10.5005/jp-journals-10084-12173

License: CC BY-NC 4.0

Published Online: 01-03-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Introduction: About 30% of women may have unexplained uterine bleeding at some stage in their lives. There are considerable costs to both the economy and the health sector, in addition to the direct effects on the woman and her family. After excessive bleeding has been established, the acronym PALM-COEIN is increasingly being used to classify the causes. Objectives: To assess the prevalence and to find out the contributing factors of abnormal uterine bleeding (AUB). Materials and methods: A retrospective study approach was adopted with a descriptive research design. The population for the study includes women diagnosed with AUB. The tool contains demographic variables of women with AUB, clinical variables, and contributing factors to assess AUB by using PALM-COEIN classification. Results: With regard to age, the maximum 213 (78%) were in a group of 40 years and above. In the menstrual cycle, 159 (58.2%) were having a regular cycle. Out of 273 women, 202 (74%) have no previous history of medical illness. The value of body mass index (BMI) shows 151 (55.3%) had normal BMI. The prevalence rate was 6.94%. About 93 (34.1%) had maximum contributing factor with adenomyosis. Then, 50 (18.3%) had iatrogenic as a contributing factor. There is no malignancy and hyperplasia and coagulopathy as a contributing factor. According to the findings of this report, AUB can cause unnecessary disruption in women's daily activities, as well as serious medical consequences or exacerbation of anemia.

  1. Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011;29(5):383. DOI: 10.1055/s-0031-1287662.
  2. Munro MG, Critchley HO, Fraser IS. The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding. Semin Reprod Med 2011;29(05):391–399. DOI: 10.1055/s-0031-1287663.
  3. Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive aged women. Obstet Gynecol 2012;120(1):197–206. DOI: 10.1097/AOG.0b013e318262e320.
  4. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2016;34(54):65. DOI: 10.1016/j.bpobgyn.2015.11.012.
  5. Deneris A. PALM‐COEIN nomenclature for abnormal uterine bleeding. J Midwi Women's Health 2016;61(3):376–379. DOI: 10.1111/jmwh.12440.
  6. Choudhury SA, Nath P. Abnormal uterine bleeding; its prevalence, causes and management in a tertiary care hospital. New Indian J Obgyn 2020;7(1):52–57. DOI: 10.21276/obgyn.2020.7.11.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.